IP Library › Assignment 055967/0230
Patent Assignment
Reel/Frame 055967/0230

Change of Name

Recorded: 2021-04-19 Pages: 4
Assignor
ADARE PHARMACEUTICALS US, L.P.
Executed: 2020-09-30
Assignee
ELLODI PHARMACEUTICALS, L.P.
1200 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Property (1)
Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
Application: 16/578,568 →
Publication: US 2020/0016171
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 23, 2019
From: GOSSELIN, MICHAEL A.; LAI, JIN-WANG; VENKATESH, GOPI M.
To: APTALIS PHARMATECH, INC.
Reel/Frame 050461/0439 →
Change of Name Sep 23, 2019
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 050462/0358 →
Assignment of Assignor's Interest Jan 7, 2020
From: ADARE PHARMACEUTICALS, INC.
To: ADARE DEVELOPMENT I, L.P.
Reel/Frame 051435/0763 →
Change of Name Jan 7, 2020
From: ADARE DEVELOPMENT I, L.P.
To: ADARE PHARMACEUTICALS US, L.P.
Reel/Frame 051494/0462 →